Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Change in Cash (2018 - 2025)

Historic Change in Cash for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$10.4 million.

  • Health Catalyst's Change in Cash fell 10823.13% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$288.0 million, marking a year-over-year decrease of 22342.6%. This contributed to the annual value of $143.4 million for FY2024, which is 152854.72% up from last year.
  • As of Q3 2025, Health Catalyst's Change in Cash stood at -$10.4 million, which was down 10823.13% from -$291.3 million recorded in Q2 2025.
  • Health Catalyst's Change in Cash's 5-year high stood at $126.4 million during Q3 2024, with a 5-year trough of -$291.3 million in Q2 2025.
  • In the last 5 years, Health Catalyst's Change in Cash had a median value of $525000.0 in 2024 and averaged -$2.7 million.
  • In the last 5 years, Health Catalyst's Change in Cash surged by 90184.29% in 2021 and then tumbled by 5557733.33% in 2025.
  • Health Catalyst's Change in Cash (Quarter) stood at -$82.5 million in 2021, then soared by 90.41% to -$7.9 million in 2022, then skyrocketed by 242.88% to $11.3 million in 2023, then tumbled by 795.99% to -$78.7 million in 2024, then surged by 86.77% to -$10.4 million in 2025.
  • Its Change in Cash was -$10.4 million in Q3 2025, compared to -$291.3 million in Q2 2025 and $92.3 million in Q1 2025.